An HPLC method for determination of oridonin in rabbits using isopsoralen as an internal standard and its application to pharmacokinetic studies for oridonin-loaded nanoparticles

An HPLC method for determination of oridonin in rabbits using isopsoralen as an internal standard and its application to pharmacokinetic studies for oridonin-loaded nanoparticles
复制标题

DOI:
10.1016/j.jchromb.2008.05.005
复制
发表时间:
2008-06-15
影响因子:
3
通讯作者:
Wei, Li
Wei, Li
中科院分区:
医学3区
文献类型:
--
作者:
Mei, Yinghao;Xu, Jie;Wei, Li

文献摘要

被引文献

相似文献

建立了测定家兔血浆中冬凌草甲素浓度的高效液相色谱法。采用简单的液-液萃取(LLE)方法从家兔血浆中提取ORI和内标物异补骨脂素(IS)。采用Kronnasil C18 5 μ m色谱柱(250 mm x 4.6 mm),以甲醇-水(50:50,v/v)为移动的相,流速为1 mL/min,紫外检测波长为241 nm。定量下限(LLOQ)为0.02 μ g/mL。校准曲线在0.02-10 μ g/mL的浓度范围内呈线性。含量测定准确度和精密度分别在95.1-113.5%和5.4- 8.6%范围内。该HPLC方法成功地应用于ORI负载的聚(己内酯)-聚(环氧乙烷)-聚(己内酯)共聚物纳米颗粒(ORI-PCL-PEO-PCL-NP)在兔体内的药代动力学研究,以相当于2 mg ORI/kg的剂量单次静脉注射给药,并将ORI的药代动力学参数与单次静脉注射相同剂量的ORI溶液进行比较。(c)2008 Elsevier B. V.保留所有权利。
A simple and sensitive HPLC method has been developed and validated for the determination of oridonin (ORI) in rabbit plasma. A simple liquid-liquid extraction (LLE) method was applied to extract ORI and the internal standard (IS), isopsoralen, from rabbit plasma. Chromatographic separation of ORI and the IS was achieved with a Kronnasil C18 5-mu m column (250 mm x 4.6 mm) using methanol-water (50:50, v/v) as mobile phase at a flow rate of 1 mL/min. The ultraviolet (UV) detection wavelength was set at 241 nm. The lower limit of quantification (LLOQ) was 0.02 mu g/mL. The calibration curves were linear over a concentration range of 0.02-10 mu g/mL. The assay accuracy and precision were within the range of 95.1-113.5% and 5.4-8.6%, respectively. This HPLC method was applied successfully to the pharmacokinetic study of ORI-loaded poly(caprolactone)-poly(ethylene oxide)-poly(caprolactone) copolymer nanoparticles (ORI-PCL-PEO-PCL-NP) in rabbits, given as a single intravenous injection at the dose equivalent to 2 mg of ORI/kg, and the pharmacokinetic parameters for ORI were compared with a single intravenous injection of a ORI solution at the same dose. (c) 2008 Elsevier B.V. All rights reserved.